Increased Costs Associated With Proposed State Legislation Impacting PBM Tools
Visante was commissioned by the Pharmaceutical Care Management Association (PCMA) to estimate the potential cost impact of four types of state legislation impacting pharmacy benefit management (PBM)...
View ArticlePCMA Offers Policy Solutions to Reduce Prescription Drug Costs
(Washington, D.C.) — As Congress begins to examine high prescription drug prices, the Pharmaceutical Care Management Association (PCMA) sent letters to several congressional committees highlighting the...
View ArticlePCMA Statement on the Administration’s Prescription Drug Rebate Proposed Rule
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and Human Services Office of Inspector General’s proposed...
View ArticlePCMA Unveils New Campaign on the Value of Pharmacy Benefit Managers
As the debate on high-cost prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care Management Association (PCMA) today is...
View ArticlePCMA Launches New Campaign: ‘Protect the Savings’ for Medicare Beneficiaries,...
(Washington, D.C.) —The Pharmaceutical Care Management Association (PCMA) is launching a new print and digital ad campaign – “Protect the Savings” – to defend the savings that pharmacy benefit managers...
View ArticlePCMA Statement on Senate Finance Committee Hearing on Drug Prices
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Senate Finance Committee hearing, “Drug Pricing in America: A...
View ArticlePCMA Statement on Pennsylvania Auditor General Drug Pricing Report
(Washington, D.C.) — The Pharmaceutical Care Management Association released the following statement on the Pennsylvania Auditor General’s report, “Bringing Transparency & Accountability to Drug...
View ArticleIndependent Drugstore Lobby Agenda Increases Prescription Drug Costs for New...
(Washington, D.C.) — As drugstore lobbyists descend on Albany today, it is important to highlight how pharmacy benefit managers (PBMs) advocate for consumers and health plan sponsors in the fight to...
View ArticlePCMA Statement on Prescription Drug Rebate Legislation
(Washington, D.C.) — Pharmaceutical Care Management President and CEO JC Scott issued the following statement on newly introduced legislation by Senator Mike Braun (R-Ind.), “The Drug Price...
View ArticlePCMA Statement on Congressional Committee Hearings on Drug Prices
(Washington, D.C.) — As several congressional committees today examine prescription drug pricing issues Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the...
View Article
